Ddx3x encodes a DEAD box RNA helicase implicated in antiviral immunity and tumorigenesis. 36
Introduction 47
RNA helicases are key regulators of gene expression that control almost all aspects of RNA 48 metabolism from synthesis to degradation (1). The largest group of RNA helicases, the DEAD 49 (Asp-Glu-Ala-Asp) box family, contain a characteristic DEAD-box and a helicase-C domain (2). 50
Recent evidence reveals crucial unexpected roles for DEAD-box helicases in antiviral immunity 51 (3) (4) (5) (6) (7) (8) (9) . 52 DDX3X (DEAD-Box Helicase 3, X-linked) is a ubiquitously expressed helicase implicated in 53 innate immunity and control of virus replication (9) (10) (11) (12) . DDX3X has a homolog on the Y 54 chromosome, DDX3Y (91% identity), which is putatively only expressed in testis (13) (14) (15) . The 55 amino acid sequence homology between human and mouse DDX3X is >98%, implying 56 evolutionary conservation (16) . The ATP-dependent RNA helicase functions of DDX3X are 57 involved in several steps of RNA processing that ultimately promote translation (17) (18) (19) . These 58 functions likely relate to the role of DDX3X in cell cycle control, apoptosis, and tumorigenesis 59 (18) (19) (20) (21) . In addition, DDX3X participates in innate immune nucleic acid sensing that promotes 60 interferon-beta (IFN-β) (12, 22) . Given this myriad of functional roles, it is not surprising that 61 DDX3X is targeted by several viruses to evade host immune responses and promote virus 62 replication (10, 19, 23) . 63 DDX3X is broadly expressed in hematopoietic cells (24) and mutations in DDX3X are linked to 64 various cancers (18), including leukemia and lymphoma. Yet, the function of DDX3X in 65 leukocytes remains largely unexplored. Since global deletion of Ddx3x is embryonically lethal 66 (25), we generated a novel mouse model characterized by Vav1-Cre-driven deletion of floxed 67
Ddx3x alleles in hematopoietic cells. We discovered a crucial function for Ddx3x in hematopoiesis, Ddx3x wt/y Vav1-Cre ± ). We used C57BL/6 CD45.1 + (BoyJ) mice from Jackson Laboratory (#002014) 78 in bone marrow transplantation experiments. Mice were housed in a specific pathogen-free barrier 79 facility, and experiments conducted with approval from the Cincinnati Children's Institutional 80
Animal Care and Use Committee. Mice were used when 6 to 12 weeks old unless otherwise 81 specified. 82
Tissue harvest, cell isolation, and flow cytometry. To examine bone marrow cells, mouse femura 83 and tibias were flushed with 1× PBS (Corning) using a 10-mL syringe and a 26-gauge 3/8-inch 84 needle (BD Worldwide). We filtered the resulting cell suspension through a 70μm filter mesh 85 (Corning). Mouse spleens and lymph nodes were harvested and mashed on top of the 70μm filter 86 mesh. Red blood cells were lysed using an ACK lysing buffer (Thermo Fisher). 87
Cells were stained with fluorochrome-labeled antibodies in 100μL flow buffer (2% fetal bovine 88 sera in PBS) for 30 minutes at 4°C, then fixed with 100μL fixation buffer for 30 minutes at 4°C. 89 Data were acquired on LSR II or Fortessa cytometers and analyzed by FACSDiva (BD Biosciences) 90 and FlowJo (TreeStar). Bone marrow small pre-B cells (CD3 -Ly6C -Ter119 -CD11b -Gr-1 -91 B220 + CD43 -IgM -IgD -) and splenic IgM + B cells (CD3 -CD19 + IgM hi ) were sorted using a 92
FACSAria II (BD Biosciences). 93 Ddx3x mice and mixed these cells at 1:1, 1:2 or 1:4 ratios. We intravenously injected 2.5 x 10 6 95 cells into lethally irradiated (700 rad + 475 rad) CD45.1 + WT recipient mice via the lateral tail 96 vein. Mice were examined 14 to 17 weeks after transplantation. 97
ELISA. Blood was collected by cardiac puncture using a 1-mL syringe and 26-gauge 3/8-inch 98 needle (BD Worldwide) and centrifuged at 3,000 rpm for 10 minutes. Supernatant was aliquoted 99 and stored at -80°C. Mouse IgA, IgG, IgM, IgE, IgG1, IgG2c, IgG2b or IgG3 measured using 100 ELISA Ready-SET-Go kits according to manufacturer's protocols (eBioscience). 101 Microarray analysis. We isolated total cellular RNA from sorted small pre-B cells using 102 mirVana™ miRNA Isolation Kit (Thermo Fisher Scientific). RNA concentration and integrity 103
were measured on an Agilent Bioanalyzer. Ovation Pico WTA kit (NuGen) was used to amplify 104 and label RNA library. The RNA libraries were evaluated using GeneChip Mouse Gene 2.0 arrays 105 (Affymetrix). RNA library preparation and GeneChip assays were performed by Cincinnati 106
Children's Gene Expression Core. Raw data were used for analysis with GeneSpring GX software 107 (v13.0, Agilent Technologies). We first applied standard RMA normalization and baseline 108 transformation to all samples (n=4/group), then removed noise by applying a filter requiring a raw 109 expression value >50. Unpaired t-tests were performed, with p<0.05 and fold change >1.5 were 110 set as benchmarks for differential gene expression between experimental groups. A hierarchical 111 clustered heatmap of the top 20 up-regulated and top 15 down-regulated genes were made using 112 RT reagent Kit (Clontech). For qPCR, 10μL SYBR Green master mix (SYBR Premix Ex Taq™ 117 II, Clontech), 0.4μL Rox dye, 1.6μL of 10μM primer mix, 6μL water, and 2μL cDNA template 118 were used in a total 20μL system per sample. Samples were run in triplicates on ABI 7500 Time PCR System (Applied Biosystems). Target genes were normalized to actin or β2-120 Microglobulin (B2M) mRNA expression levels. Forward and reverse primers used for quantitative 121 PCR (qPCR) are as follows: presented as mean ± standard deviation (SD). Unless otherwise specified, significant differences 141 were calculated using unpaired, two-tailed Student's t-test for two groups and one-way ANOVA 142 for three groups, where p value is indicated by *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, or ****p ≤ 143 0.0001. 144
145
Results 146
Ablation of Ddx3x restricts peripheral B-cell compartment 147
To evaluate the role of Ddx3x in leukocyte development and function, we utilized mice in which 148 exon 2 of Ddx3x was flanked by LoxP sites (Ddx3x fl/fl ). Expression of Cre recombinase facilitates 149 deletion of exon 2 and introduction of an early stop codon in exon 3 (Figure 1a) . We bred female 150
Ddx3x fl/fl mice to male Vav1-Cre mice (27) to facilitate deletion of Ddx3x in hematopoietic cells. 151
We generated hemizygous male mice (Ddx3x fl/y Vav1-Cre + , henceforth denoted Ddx3x), but 152 never recovered female mice with a homozygous Ddx3x fl/fl Vav1-Cre + genotype. This may reflect 153 a role for hematopoietic cells in the embryonic lethality associated with germline Ddx3x-154 deficiency (25), and a potentially compensatory role for Ddx3y in embryogenesis. Ddx3x mRNA 155 expression was reduced 80% in bone marrow and 60% in spleen CD45 + cells from hemizygous 156 male Ddx3x mice relative to Cre-negative littermate controls (Figure 1b) . 157
In Ddx3x mice, there was a 4-fold reduction in the proportion of circulating B cells as well as 158 marked reductions in the numbers of CD3 -CD19 + B cells in the inguinal lymph nodes (iLN) and 159 spleen relative to WT mice (Figure 1c ). Similar frequencies of B cells were observed in the spleen 160 of all strains of control mice examined, including mice expressing Cre but no floxed alleles of 161 Figure 1) . In the periphery, when 163 immature B cells egress from bone marrow, they go through transitional stages (T1, T2, T3) before 164 acquiring maturity. The number of CD19 + CD93 + B cells in stage T1 (IgM + CD23 -), T2 165 (IgM + CD23 + ), and T3 (IgM low CD23 + ), were reduced in the spleen of Ddx3x mice (Figure 1d) . 166 10 CD19 + CD23 + CD21 int ) and marginal zone B cells (MZB, CD19 + CD21 hi CD23 -). The spleens of 168 Ddx3x mice harbor 6.5-fold fewer FOB, but exhibit a concomitant 1.8-fold increase in the 169 number of B cells with a MZ phenotype (Figure 1e, Supplemental Figure 1 ). In addition, there 170 were 5.4-fold fewer germinal center (GC) phenotype B cells (GC-B, CD19 + CD95 + GL7 + ) and 4.2-171 fold fewer plasmablasts (CD19 int CD138 + ) in the spleen of Ddx3x mice relative to controls 172 animals (Figure 1f) . Thus, peripheral B cells are markedly reduced in Ddx3x mice. 173
Ddx3x deficiency is associated with enhanced immunoglobulin production 174
To assess whether reduced expression of Ddx3x affects B-cell activity, we measured expression of 175 activation markers on the surface of splenic B cells and the baseline levels of different 176 immunoglobulin classes in the sera of the Ddx3x and WT mice. Splenic B cells in Ddx3x mice 177 exhibit high expression levels of the costimulatory receptors, CD80 and CD86, relative to control 178 B cells (Figure 2a) . Likewise, Ddx3x B cells exhibit higher expression of MHC class II than 179 their counterparts in WT mice (Figure 2a) . These activation markers were expressed at higher 180 levels on both FOB (CD19 + CD1d low ) and MZB (CD19 + CD1d hi ) cells (data not shown). Despite a 181 reduced number of B cells and plasmablasts (Figure 1) , sera titers of IgA, IgG, and IgM were 182 elevated 1.8-to 4.1-fold in Ddx3x mice relative to littermate controls (Figure 2b) . In contrast, 183 sera IgE levels were decreased almost 9-fold in mice with reduced expression of Ddx3x ( Figure  184 2b). Among IgG subclasses, IgG1, IgG2b, and IgG3 titers were increased 1.7 to 4.2-fold while 185 
Ddx3x supports B-cell lymphopoiesis 203
The peripheral B cell lymphopenia in Ddx3x mice portends a defect in B-cell development and 204 maturation in the bone marrow. Notably, the frequency of B220 + B cells in the bone marrow was 205 reduced 1.8-fold in Ddx3x mice relative to WT counterparts (Figure 3a) . Frequencies of common 206 lymphoid progenitor (CLP, Flk2 + IL7R + ) cells were similar in the bone marrow of Ddx3x and 207 control mice. B-cell development in bone marrow is a sequential process of proliferation and BCR 208 rearrangement that occurs in discrete stages that can be delineated by flow cytometry according to 209 the Hardy classification system (32) . The frequency of pre-pro-B (BP-1 -CD24 -), late pro-B (BP-210 1 + CD24 int ), and large pro-B (BP-1 + CD24 high ) cells among lineage neg CD43 + B220 + precursors 211 appeared normal in mice with targeted deletion of Ddx3x (Figure 3b,c) . However, Ddx3x bone 212 marrow contained 3.4-fold fewer cells at the early pro-B cell (lin -CD43 + B220 + BP-1 low CD24 high ) 213 stage (Figure 3c) . Of note, the frequencies of late and large pro-B cells were normal, with similar 214 expression levels of intracellular IgM (Ddx3x = 47.2 ± 1.6%, WT = 47.5 ± 1. 3%, p=0.90, n=4, 215 Student's t-test), suggesting B cells progressing through early pro-B cell stage properly rearranged 216 heavy chain. Among lineage neg CD43 -B220 + precursors, Ddx3x mice harbored 1.8-fold fewer 217 small pre-B cells (IgM -IgD -), 2.1 -fold fewer immature B cells (IgM + IgD -), and 7.2-fold fewer 218 circulating mature B cells (IgM + IgD + ) (Figure 3c) . Thus, there is a progressive and lasting defect 219 in B-cell lymphopoiesis beginning at the small pre-B cell stage that may contribute to the 220 peripheral B-cell lymphopenia in Ddx3x mice. 221
B cell-intrinsic role for Ddx3x 222
Since Ddx3x expression is broadly reduced in the hematopoietic lineage of Ddx3x mice, the 223 changes observed in the B-cell compartment could be due to intrinsic effects of Ddx3x in 224 developing B cells. To test intrinsic role of Ddx3x in B cells, we mixed bone marrow cells from 225 CD45.2 + Ddx3x mice and CD45.1 + B6 WT mice (BoyJ), and then transplanted these cells into 226 lethally irradiated CD45.1 + B6 WT recipient mice. When donor bone marrow cells were mixed at 227 a 1:1 or 1:2 ratio, very few CD45.2 + Ddx3x cells were apparent in recipient mice 14 to 16 weeks 228 after bone marrow reconstitution (data not shown). Therefore, we generated mixed chimera mice 229 with 4-fold more Ddx3x than WT donor cells (Figure 4a) . Although CD45.2 + Ddx3x donor 230 cells became detectable by 16 weeks in this context, these cells were still outnumbered 2:1 and 231 12:1 by CD45.1 + WT-derived cells in recipient mouse bone marrow and spleen, respectively 232 (Figure 4b, c) . Thus, Ddx3x cells have a competitive disadvantage compared to WT cells. 233 Despite developing in a predominately WT environment, CD45.2 + Ddx3x donor cells in the 234 mixed bone marrow chimeric mice still demonstrated defects similar to cells in non-chimeric 235 Ddx3x mice (Figure 4d, e) . Specifically, the percentage of late/small pre-B, immature B and 236 mature B cells among CD45.2 + Ddx3x cells in the bone marrow did not reach the normal 237 proportions apparent among WT B cells in the CD45.1 + donor compartment (Figure 4d, e ) or in 238 non-chimeric mice (Figure 2) . Therefore, reduced Ddx3x expression confers both a competitive 239 disadvantage and an intrinsic defect in B-cell differentiation in the bone marrow. In the spleen of 240 the chimeric mice, the percentage and absolute number of FOB derived from CD45.2 + Ddx3x 241 donor were 18-fold lower than that derived from the CD45.1 + WT donor precursors, suggesting 242 that FOB deficit is B-cell intrinsic phenomenon (Figure 4d, e) . However, the percentage of MZB 243 derived from the two donors in these chimeric mice is similar (Figure 4d, e ), suggesting that the 244 increased frequency of MZB cells in non-chimeric Ddx3x mice (Figure 1) is a result of B cell-245 extrinsic factors. 246
Ddx3x regulates Brwd1 and Ig rearrangement in small pre-B cells 247
The loss of developing B cells apparent in Ddx3x mice is likely a result of Ddx3x activity in one 248 or more stages of B-cell development. The appearance of a prominent and lasting phenotype at the 249 pre-B stage (fraction D) of B-cell development (Figure 3) , suggests that Ddx3x likely plays an 250 important role in pre-B cells. Thus, we extracted RNA from small pre-B cells (CD3 -Ly6C -Ter119 -251
CD11b -Gr-1 -B220 + CD43 -IgM -IgD -) sorted out of the bone marrow of Ddx3x and WT mice. We 252 then analyzed gene expression using Affymetrix mouse gene 2.0 arrays. We found 477 253 differentially expressed entities/transcripts that have more than 1.5-fold expression differences 254 between Ddx3x and WT late/pre-B cells with p-value smaller than 0.05 using unpaired Student's 255 t-test. Among the 477 transcripts, 374 transcripts were expressed at higher levels in the Ddx3x 256 late/pre-B cells compared to their WT counterparts, while the remaining 103 transcripts were 257 expressed at lower levels when Ddx3x expression was reduced. Within each experimental group, 258 each individual mouse (n = 4) had a relatively similar gene expression pattern to other mice in the 259 same group (Figure 5a) . 260
Of note, Ddx3x pre-B cells exhibit 2.77-fold lower expression of Brwd1 relative to controls 261 (Figure 5a) . Brwd1 (bromodomain and WD repeat domain containing 1) encodes a protein that 262 targets and restricts recombination at the immunoglobulin Kappa (Igκ) locus in B cells (26). 263
Notably, Brwd1 mutant mice exhibited a similar B-cell phenotype to that observed in Ddx3x mice, 264 with both mouse strains exhibiting a deficiency at the late/small pre-B cell stage of B-cell 265 development in bone marrow (Figure 3) linked to peripheral B-cell lymphopenia (Figure 2) (26) . 266
Brwd1 mRNA expression is highest in bone marrow B-cell factions D, E, and F relative to fractions 267 A, B, and C (Immgen (24)). We therefore hypothesized that Ddx3x promotes upregulation of 268 To test our hypothesis, we first confirmed the expression of Brwd1 by quantitative PCR (qPCR). 271
We found that Brwd1 expression was decreased by ~9-fold in late/small pre-B cells of Ddx3x 272 mice (Figure 5b) . Before Kappa DNA rearrangement happens, a germline transcript is expressed 273 as a consequence of chromatin accessibility of the Kappa locus (33). Of note, we found decreased 274 germline Ig expression in the Ddx3x mice (Figure 5c ). We used semi-quantitative PCR to 275 demonstrate that rearrangement of Vκ-Jκ was also diminished 20-30% in the Ddx3x late/small 276 pre-B cells compared to WT cells (Figure 5d,e) . In this assay, spleen-derived WT IgM + B cells 277 served as positive control for Kappa rearrangement. In addition, qPCR specifically for Vκ-Jκ1 278 showed a similar 2.3-fold reduction in V-J1 rearrangement in cells with reduced Ddx3x 279 expression compared to controls (Figure 5f) . These data demonstrate that B-cell light chain kappa 280 rearrangement is deficient in the Ddx3x mice. In order to facilitate light chain rearrangement, 281 developing B cells must efficiently exit the cell cycle at the small pre-B cell stage. In conjunction 282 with reduced light chain rearrangement, more small pre-B cells in Ddx3x mice stain positive for 283
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